Take Your Trading To The Next Level. Get Started Here!

FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

November 8, 2023 Comments Off

The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.